Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer

• Laleh Naghibi,

  Roles Investigation

  Affiliations Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran

  ⨯
• Mona Yazdani,

  Roles Project administration, Writing – review & editing

  Affiliation Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  ⨯
• Amir Abbas Momtazi-Borojeni,

  Roles Writing – review & editing

  Affiliation Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

  ⨯
• Atefeh Razazan,

  Roles Writing – original draft

  Affiliation Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

  ⨯
• Sheida Shariat,

  Roles Project administration

  Affiliation Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  ⨯
• Mercedeh Mansourian,

  Roles Project administration

  Affiliations Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran

  ⨯
• Atefeh Arab,

  Roles Project administration

  Affiliations Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran, Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  ⨯
• Nastaran Barati,

  Roles Project administration

  Affiliation Vice Chancellor for Research and Technology, Hamadan University of Medical Science, Hamadan, Iran

  ⨯
• Mahdieh Arabsalmani,

  Roles Project administration

  Affiliation Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  ⨯
• Azam Abbasi,

  Roles Project administration

  Affiliation Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  ⨯
• Zahra Saberi,

  Roles Project administration

  Affiliation Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  ⨯
• Ali Badiee ,

  Roles Supervision

  * E-mail: Jafarimr@mums.ac.ir (MRJ); Jalalia@sbmu.ac.ir (SAJ); Badieea@mums.ac.ir (AB)

  Affiliations Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran

  ⨯
• Seyed Amir Jalali ,

  Roles Supervision

  * E-mail: Jafarimr@mums.ac.ir (MRJ); Jalalia@sbmu.ac.ir (SAJ); Badieea@mums.ac.ir (AB)

  Affiliation Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

  https://orcid.org/0000-0003-1174-4905

  ⨯
• Mahmoud Reza Jaafari

  Roles Supervision

  * E-mail: Jafarimr@mums.ac.ir (MRJ); Jalalia@sbmu.ac.ir (SAJ); Badieea@mums.ac.ir (AB)

  Affiliations Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran, Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

  https://orcid.org/0000-0003-3908-6828

  ⨯